Home › Funds › Aequim Alternative Investments LP › RGEN

Aequim Alternative Investments LP position in RGEN

Repligen Corp · Health Care

Aequim Alternative Investments LP reported holding 30,000,000 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$35.1M, representing 0.70% of its reported portfolio and ranking #33 among its reported holdings. Aequim Alternative Investments LP has disclosed RGEN holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.00M sh
Reported value held$35.07M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aequim Alternative Investments LP's RGEN position evolved

Aequim Alternative Investments LP first disclosed a stake in RGEN in Q3 2023 at 60,500,000 shares (US$39.1M). The position peaked in Q4 2025 at 81,350,000 shares, worth US$89.3M. Across 10 filings, Aequim Alternative Investments LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 30,000,000 shares valued at US$35.1M — a reduction of -45,000,000 shares quarter over quarter.. Notable position changes include a 60% trim in Q3 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 60.50M $39.14M New
Q4 2023 50.00M $56.05M Reduce
Q4 2024 45.00M $46.12M New
Q1 2025 48.50M $47.43M Add
Q2 2025 58.50M $58.24M Add
Q3 2025 70.00M $70.56M Add
Q4 2025 81.35M $89.28M Add
Q1 2026 81.35M $79.48M Hold
Q2 2026 75.00M $77.09M Reduce
Q3 2026 30.00M $35.07M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Aequim Alternative Investments LP held RGEN?

Aequim Alternative Investments LP has disclosed RGEN holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Aequim Alternative Investments LP's current position in RGEN?

As of Q3 2026, Aequim Alternative Investments LP holds 30.00M shares of RGEN (Repligen Corp), valued at $35.07M, representing 0.70% of its reported portfolio and ranking #33.

Has Aequim Alternative Investments LP been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Aequim Alternative Investments LP reduced its position in RGEN. The position peaked in Q4 2025 at 81.35M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.